WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

“A STUDY OF RELATIVE EFFICACY OF KAUTAJADI SHILAJATU [SHILAJATU VATAK] WITH NAVAYAS CHURNA IN GARAVISHAJANIT PANDU”

Atul Acharya* and Dr. P.D. Namewar

ABSTRACT

So regularly, Continues and untimely consuming Viruddhahar for long time there is formation of Garavisha results in Aganimandya leading to dosh dusti especially Pitta Dosha and dhatu dusti leading to dhatushaithilya resulting Bal, Varna and Ojakashya and subsequently manifests as Pandu showing symptoms as Daurbalya, Annadavit, Shram, Bhram, Aruchi, Akshikotshooth, Hatprabha etc. Total 30 patients were diagnosed of Garavishajanit Pandu on the basis of subjective and objective parameters and subjected to clinical trials conducted at Bharati Vidyapeeth Medical Foundation’s Ayurved Hospital and Research Center, Katraj, Pune. After filling preliminary data and acceptance to informed consent, Enrolled patients were alloted in both groups 15 in each group at random by lottery method and they have received the medicine by single blind method. IEC clearance and Informed consent were taken prior to commencement of study. Trial Group-1(Kautajadi Shilajatu) and Trial group-2(Navayas Churna) were administered respectively Kautajadi Shilajatu and Navayas churna at Vyanodane with dose 250mg for 28 days. Appropriately graded Subjective and objective parameters were assessed on weekly basis. Result were noted significant in symptoms Hatanal, Akshikootshoth, Daurbalya, Kopan, Annadvit, Pindikodwesthan, Shram, Hatprabha, Bhram, Gatrashool, Shwas, Aruchi in both groups and also increase in Hb% and Normal RBCs morphology. Group T-1 more effective than Group T-2.

Keywords: Viruddhahar, Garvisha, Pandu, Kautajadi Silajatu(Shilajatu Vatak), Navayas Churna.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More